|1.||Zollinger, Terrell: 1 article (07/2013)|
|2.||Zhang, Jianjun: 1 article (07/2013)|
|3.||Beshir, Safia: 1 article (07/2013)|
|4.||Elserougy, Safaa: 1 article (07/2013)|
|5.||Wang, Ling: 1 article (07/2013)|
|6.||Saad-Hussein, Amal: 1 article (07/2013)|
|7.||Ibrahim, Mohamed I M: 1 article (07/2013)|
|8.||Moubarz, Gehan: 1 article (07/2013)|
|9.||Peng, Kai-Yao: 1 article (05/2009)|
|10.||Chen, Chia-Yang: 1 article (05/2009)|
|1.||Liver Neoplasms (Liver Cancer)
05/01/2009 - "Prevalence of aflatoxin M1 in milk and its potential liver cancer risk in Taiwan."
07/01/1993 - "617 children in high and low liver cancer incidence areas of Guangxi were observed for a study on the relationship between the dietary Aflatoxin B1 (AFB1) levels and Aflatoxin M1 (AFM1) excretion amounts in urine. "
07/01/2013 - "pylori prevalence with HBsAg positivity and urinary aflatoxin M1 in men in relation to liver cancer mortality. "
|2.||Hepatocellular Carcinoma (Hepatoma)
01/01/1985 - "Cancer risks posed by aflatoxin M1."
06/01/2006 - "The principal Aflatoxin B(1) (AFB(1)) hydroxylated metabolite excreted in milk is Aflatoxin M(1) (AFM(1)) classified in group 2B by the International Agency for Research on Cancer (IARC). "
03/01/1980 - "Administration of 50 ppm methyl sterculate, a cyclopropenoid fatty acid, in combination with 100 ppb AFQ1 resulted in a synergistic tumor response similar to that previously noted with administration of AFB1 plus aflatoxin M1. "
07/01/2013 - "Skin prick tests, urinary Aflatoxin M1 (AFM1) and the tumor biomarkers (alpha-fetoprotein (AFP), alpha-L-fucosidase (AFU), insulin-like growth factors (IGF-1) were measured. "
|4.||Odontogenic Tumors (Dental Tissue Neoplasm)
|1.||Aflatoxin B1 (Aflatoxin B)
|2.||Biological Markers (Surrogate Marker)
|4.||Hepatitis B Surface Antigens (HBsAg)
|10.||aflatoxicol (aflatoxin R)